Home › Peptides › Tirzepatide

Is Tirzepatide safe?

Approved

Tirzepatide is an approved prescription medicine for type 2 diabetes and chronic weight management, with strong trial evidence and the same class of side effects as semaglutide.

Approved by the FDA and/or Health Canada for at least one human indication. Safety has been characterised in clinical trials and is described on an official product label. Approved does not mean safe for everyone, or safe outside the indication it was approved for.

Updated October 2026 · Checked against Eli Lilly (sponsor), Health Canada (Recalls & Safety Alerts), FDA, PubMed

Name: Tirzepatide
Also known as: Mounjaro, Zepbound
Class: Dual GIP and GLP-1 receptor agonist
Verdict: Approved Approved by a regulator for a human indication
Human evidence: Strong
Updated: October 2026

What is Tirzepatide?

Tirzepatide activates two gut hormone receptors, GIP and GLP-1, which together reduce appetite, slow stomach emptying and improve insulin release. It is a once-weekly injection sold as Mounjaro (type 2 diabetes) and Zepbound (chronic weight management). Eli Lilly developed it and ran large phase 3 programs, so its benefits and risks are far better documented than most peptides sold online.

What it is claimed to do

These are the uses Tirzepatide is promoted for. Listing a claim is not endorsing it — the next section is where each one meets the evidence.

Blood sugar control in type 2 diabetes
Chronic weight management in adults with obesity, or overweight plus a weight-related condition
In the US, treatment of obstructive sleep apnea in adults with obesity

What the human evidence shows

Evidence: StrongMultiple randomised controlled trials in humans, or a systematic review of them, reporting consistent results on an outcome that matters.

In SURMOUNT-1 (New England Journal of Medicine, 2022), adults with obesity or overweight and no diabetes who took the highest dose studied lost an average of about 21% of body weight over 72 weeks, compared with about 3% on placebo. In SURMOUNT-5, a head-to-head trial reported by Lilly in late 2024, tirzepatide produced about 20% average weight loss versus about 14% for semaglutide at 72 weeks. As with semaglutide, benefits depend on continued treatment alongside diet and activity changes.

Known risks and side effects

Common: nausea, diarrhea, vomiting, constipation and abdominal pain, most often during dose increases.
Serious but less common: pancreatitis, gallbladder problems, and kidney injury from dehydration.
Thyroid C-cell tumours appeared in rodents; the US label carries a boxed warning and it is not used in people with a history of medullary thyroid carcinoma or MEN 2.
It may make oral birth control pills less effective after starting or increasing the dose, so prescribers usually advise a backup method.
Unapproved or compounded copies add risks of dosing error and unknown quality.

Legal status

Regulatory status as of October 2026. Approval, prescription status and compounding restrictions change without notice, and the two countries move independently. Check the regulator directly before relying on any of it.

United States

Approved for human use: Yes — approved by the FDA for at least one indication
Prescription only: Yes — available only on a prescription

FDA-approved prescription drug. The FDA says unapproved and compounded tirzepatide products are not FDA approved and are not reviewed for safety, effectiveness or quality. As of May 31, 2026 it had received more than 730 adverse event reports for compounded tirzepatide, and it notes these are likely underreported.

Canada

Approved for human use: Yes — approved by Health Canada for at least one indication
Prescription only: Yes — available only on a prescription

Authorized by Health Canada as a prescription drug. Mounjaro is authorized for type 2 diabetes (including children aged 10 and older), and Zepbound KwikPen was authorized on May 13, 2025 for chronic weight management in adults. Health Canada warns that unauthorized semaglutide and tirzepatide products sold online have not been assessed for safety, effectiveness or quality.

Who should avoid Tirzepatide

You are pregnant, planning pregnancy, or breastfeeding.
You or a close relative have had medullary thyroid carcinoma or MEN 2.
You have a history of pancreatitis or serious stomach problems, unless your prescriber says otherwise.
You use oral birth control and have not discussed backup contraception with your prescriber.

Frequently asked questions

Is tirzepatide safe?

Tirzepatide is approved by Health Canada and the FDA for specific uses and has large trials behind it. Digestive side effects are common, and rare serious risks exist, so it should be prescribed and monitored by a clinician. Products obtained outside a licensed pharmacy are not covered by that evidence.

Is tirzepatide better than semaglutide?

In the SURMOUNT-5 head-to-head trial reported by Lilly, average weight loss was higher with tirzepatide at 72 weeks. Which drug suits a person also depends on cost, coverage, side effects, medical history and availability, which is a conversation for a prescriber.

Can I buy tirzepatide online without a prescription?

Not legitimately. It is a prescription drug in both Canada and the US, and Health Canada warns that unauthorized versions sold online have not been assessed for safety, effectiveness or quality.

Sources

Eli Lilly (sponsor)Lilly Canada: Zepbound KwikPen approved in Canada
Eli Lilly (sponsor)Lilly Canada: Mounjaro approved for children 10 and older with type 2 diabetes
Eli Lilly (sponsor)Lilly Canada: SURMOUNT-5 head-to-head trial
Health Canada (Recalls & Safety Alerts)Health Canada advisory on fake or unauthorized GLP-1 drugs (January 2026)
FDAFDA: concerns with unapproved GLP-1 drugs used for weight loss
PubMedSURMOUNT-1 trial, New England Journal of Medicine (2022)

Browse all 16 peptides →

Educational information only. This page summarises published evidence and regulatory records about Tirzepatide. It is not medical advice, it is not a recommendation for or against use, and it cannot account for your history, medications or conditions — that is a conversation for a licensed clinician.We sell nothing, name no seller, and carry no affiliate or vendor links. See the full disclaimer and ourmethodology.